It has been tested on patients with Crohn's disease and multiple sclerosis but has not yet received U.S. Food and Drug Administration licensing.
The treatment has been evaluated in patients suffering from Crohn's disease and multiple sclerosis but lacks U.S. Food and Drug Administration certification.